Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Washington
- Study ID
- NCT05822609
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Diabetic Kidney Disease
- Type 1 Diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Semaglutide — DRUG1.0 mg
- Placebo — OTHERPlacebo
Study Details
The primary objective of this study is to determine the effects of semaglutide on change in albuminuria from baseline to 26 weeks in type 1 diabetes. The secondary objective is to determine the effects of semaglutide on change in kidney parameters (including kidney oxygenation and function) measured by MRI from baseline to 26 weeks in type 1 diabetes. Other objectives are to determine the glycemic effects and safety of semaglutide in type 1 diabetes.
Key Dates
- Start date
- Apr 5, 2024
- Status verified
- May 2026
- Primary completion
- Jun 30, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: SemaglutideSemaglutide group from 0.25mg to 1.0mg
- Placebo Comparator: PlaceboPlacebo group
Primary Outcome Measure
Change in urine albumin excretion [ Time Frame: Baseline to 26 weeks ]
Central Contacts
- Ernest Ayers, MSPH206-685-1423
- Leila Zelnick, PhD206-543-2981
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | Jessica Kendrick, MD (PRINCIPAL_INVESTIGATOR) |
| University of Washington | Seattle | Washington | 98104 | Irl Hirsch, MD (PRINCIPAL_INVESTIGATOR) |
| Providence Sacred Heart Medical Center | Spokane | Washington | 99204 | Katherine Tuttle, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Aurora, CO
By condition
By specialty
Related Studies
- Combined Antibody Screening for Celiac and Diabetes EvaluationEnrolling By Invitation · Pacific Northwest Research Institute · Seattle, Washington
- Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)Recruiting · Petter Bjornstad · Aurora, Colorado
- MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 DiabetesPHASE1 · Recruiting · Kalie Tommerdahl · Aurora, Colorado
- Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up StudyEnrolling By Invitation · University of Colorado, Denver · Aurora, Colorado